Stock Research: Coloplast

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Coloplast

CPSE:COLO B DK0060448595
26
  • Value
    17
  • Growth
    67
  • Safety
    Safety
    30
  • Combined
    15
  • Sentiment
    58
  • 360° View
    360° View
    26
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Coloplast A/S is a healthcare company that develops, markets, and sells intimate healthcare products and services. It operates in the healthcare sector with a focus on Ostomy Care, Continence Care, Urology Care, and Wound & Skin Care. The company supplies products to hospitals, institutions, wholesalers, and pharmacies and operates in Denmark. In the last fiscal year, the company had a market cap of $21,405 million, profits of $2,729 million, and revenue of $4,038 million and 16,247 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 26 (better than 26% compared with alternatives), overall professional sentiment and financial characteristics for the stock Coloplast are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Coloplast. The consolidated Growth Rank has a good rank of 67, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 67% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 58, which means that professional investors are more optimistic about the stock than for 58% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 30, which means that the share price of Coloplast is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 70% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 17, which means that the company has a financing structure that is riskier than those of 83% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
OMX C20
Dividends Europe
Employee Focus EU
Human Rights
Renewables Users
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 22 17 21
Growth
67 72 57 29
Safety
Safety
17 10 8 68
Sentiment
58 46 49 30
360° View
360° View
26 15 8 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
11 15 28 31
Opinions Change
49 50 39 34
Pro Holdings
n/a 80 42 45
Market Pulse
75 47 78 54
Sentiment
58 46 49 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 22 17 21
Growth
67 72 57 29
Safety Safety
17 10 8 68
Combined
15 12 4 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
25 19 17 8
Price vs. Earnings (P/E)
9 7 6 7
Price vs. Book (P/B)
5 3 1 3
Dividend Yield
90 86 78 82
Value
30 22 17 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
70 71 65 58
Profit Growth
82 34 61 14
Capital Growth
65 86 36 36
Stock Returns
13 44 47 55
Growth
67 72 57 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
8 5 14 58
Refinancing
7 1 5 13
Liquidity
70 65 52 96
Safety Safety
17 10 8 68

Similar Stocks

Discover high‑ranked alternatives to Coloplast and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carrefour

ENXTPA:CA
Country: France
Industry: Hypermarkets, Super Centers
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.